1. Web alert

   News Pages: 91 - 91

2. Literature alert

   Abstract Pages: 92 - 94

3. Methotrexate shows marginal clinical efficacy in early scleroderma

   • John Varga

   Clinical Trials Report Pages: 97 - 98

4. The genetics of systemic sclerosis

   • Randall W. Johnson
   • Monty B. Tew
   • Frank C. Arnett

   OriginalPaper Pages: 99 - 107

5. Evaluation and management of pulmonary fibrosis in scleroderma

   • Barbara White

   OriginalPaper Pages: 108 - 112

6. Scleroderma-like cutaneous syndromes

   • Yasuji Mori
   • Veli-Matti Kahari
   • John Varga

   OriginalPaper Pages: 113 - 122

7. Raynaud’s phenomenon: Epidemiology and risk factors

   • Liana Fraenkel

   OriginalPaper Pages: 123 - 128

8. Apoptosis and myofibroblasts in the pathogenesis of systemic sclerosis

   • Eugene Kissin
   • Joseph H. Korn

   OriginalPaper Pages: 129 - 135

9. Connective tissue growth factor: A new and important player in the pathogenesis of fibrosis

   • Andrew Leask
   • Alan Holmes
   • David J. Abraham

   OriginalPaper Pages: 136 - 142

10. Control of connective tissue gene expression by TGFβ: Role of smad proteins in fibrosis

    • Franck Verrecchia
    • Alain Mauviel

    OriginalPaper Pages: 143 - 149

11. Animal models for scleroderma: An update

    • Yan Zhang
    • Anita C. Gilliam

    OriginalPaper Pages: 150 - 162

12. Reflex sympathetic dystrophy

    • Robert J. Schwartzman
    • Anca Popescu

    OriginalPaper Pages: 165 - 169

13. Nonpulmonary manifestations of sarcoidosis

    • Stephen J. Oliver

    OriginalPaper Pages: 170 - 178

14. Rheumatic manifestations of primary hyperparathyroidism and parathyroid hormone therapy

    • Mishaela R. Rubin
    • Shonni J. Silverberg

    OriginalPaper Pages: 179 - 185